
Brain Research Bulletin, Journal Year: 2024, Volume and Issue: 220, P. 111137 - 111137
Published: Nov. 20, 2024
Postoperative cognitive dysfunction (POCD) is a common complication in patients who undergo anesthesia different types of surgeries. Emerging evidence implicates elevated beta-amyloid (Aβ) the pathogenesis POCD. Meanwhile, Dexmedetomidine (DEX) has recently shown promise reducing POCD incidence. This study aimed to elucidate role Aβ inducing endothelial permeability cerebral microvascular cells and underlying mechanisms testing effects DEX. We demonstrated that Aβ1-42, prevalent form related POCD, cytotoxic HBMECs, increasing transendothelial mitochondrial dysfunction, as evidenced by reactive oxygen species (ROS) decreased ATP production membrane potential. Furthermore, Aβ1-42 was inhibit Sirt3, exacerbating dysfunction. Conversely, DEX found prevent Aβ1-42-induced increases preserved tight junction proteins HBMECs.These findings suggest DEX, Sirt3 activator, may offer pharmacological strategy mitigate Aβ1-42-related cell preserve function post-surgery.
Language: Английский